Skip to main content

Historical Aspects of Tuberculosis

  • Chapter
Tuberculosis

Abstract

Tuberculosis was first described by ancient Egyptian doctors who described clearly the clinical features and medical and surgical treatment of scrofula (Fig.8, Chap. 1). The Ancient Egyptian artists contributed to the description through their exquisite paintings, which showed spinal tuberculosis and its gibbous deformity (Fig. 1, Chap. 1). The first known sanatorium in the history of mankind was established by the Ancient Egyptians and is now open to visitors (Fig. 9, Chap. 1). Archaeological and anthropological studies indicated that tuberculosis infected the Chinese, Indo-European and pre-Columbian American tribes (Buikstra 1983; Powell 1992; Verano and Ubelaker 1992; Paulsen 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Al-Amoud M (1993) The history of tuberculosis. Saudi Med J 14:515–520

    Google Scholar 

  • Bishop PJ (1973) Thomas Young and his’ A practical and historical treatise on consumptive diseases’, 1815. Tubercle 54:159–164

    Article  PubMed  CAS  Google Scholar 

  • Bishop PJ (1981) Laennec: a great Student of tuberculosis. Tubercle 62:129–134,147-148

    Article  PubMed  CAS  Google Scholar 

  • Bishop PJ, Neumann G (1970) The history of the Ziehl-Neelsen stain. Tubercle 51:196–206

    Article  PubMed  CAS  Google Scholar 

  • British Medical Research Council (1950) Treatment of pulmonary tuberculosis with streptomycin and para-aminosalicydic acid: a Medical Research Council investigation. BMJ 2:1073–1085

    Article  Google Scholar 

  • British Medical Research Council (1962) Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation: a report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee. Tubercle 43:201–219

    Article  Google Scholar 

  • Brock TD (1999) Robert Koch-a life in medicine and bacteriology. ASM Press, Washington DC

    Google Scholar 

  • Buikstra JE (1983) Prehistoric tuberculosis in the Americas (Evanston, 111.: Northwestern University Archeological Program, 1981) (reviewed by William D Sharpe). Trans Stud Coll Phys Phil 5(5):278–281

    Google Scholar 

  • Calmette A (1923) Tubercle Bacillus Infection and tuberculosis in Man and Animals (trans WB Soper and GH Smith). Williams and Wilkins, Baltimore MD (quoted by Evans CC, 1998, Clinical tuberculosis, 2nd edn. Davies, Chapman and Hall Medical)

    Google Scholar 

  • Canetti G (1962) The eradication of tuberculosis: theoretical problems and practical Solutions. Tubercle 43:301–321

    Article  PubMed  CAS  Google Scholar 

  • Chadwick J, Mann WN (1978) Hippocratic writings. Penguin, New York, pp 117–118

    Google Scholar 

  • Chorine V (1942) Action de I’amide nicotinique sur les bacilles du genre Mycobacterium. CR Acad Sei (Paris) 220: 150–151

    Google Scholar 

  • Cooke RE, Dunphy DL, Blake FG (1946) Streptomycin in tuberculous meningitis. Yale J Bio Med 18:221–226

    CAS  Google Scholar 

  • Crawfurd R (1911) The king’s evil. Oxford

    Google Scholar 

  • Cruse JM (1999) History of medicine: the metamorphosis of scientific medicine in the ever-present past. Am J Med Sei 318:171–180

    Article  CAS  Google Scholar 

  • East African/British Medical Research Council (1973) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet 1:1331–1338

    Google Scholar 

  • East-African/British Medical Research Council (1974) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. Lancet 2:237–240

    Google Scholar 

  • Feldman WH, Karlson AG, Hinshaw HC (1947) Para-aminosalicyclic acid in experimental tuberculosis in guinea pigs. Proc Sraff Meet Mayo Clin 22:473–479

    CAS  Google Scholar 

  • Gallagher NE (1993) Islamic and Indian Medicine. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 27–34

    Chapter  Google Scholar 

  • Godfrey LG, Norman CD (1969) Surgical history of pulmonary tuberculosis: the rise and fall of various technical procedures. Can J Surg 12:381–388

    Google Scholar 

  • Hinshaw HC (1969) Tuberculosis chemotherapy: reminiscences of early clinical trials. Scand J Respir Dis 50:197–203

    PubMed  CAS  Google Scholar 

  • Hinshaw HC, Pfuetzek and Feldman WH (1944) Chemotherapy of clinical tuberculosis with promin (Promizole). Am Rev Tuber 50:52–57

    Google Scholar 

  • Hinshaw HC, Feldman WH, Pfuetze KH (1946) Treatment of tuberculosis with streptomycin. A summary of observations on one hundred cases. JAMA 132:778–782

    Article  CAS  Google Scholar 

  • Hobby GL, Lenert TF (1968) The antimycobacterial activity of Rifampin. Am Rev Respir Dis 97:713

    PubMed  CAS  Google Scholar 

  • Johnston WD (1993) Tuberculosis. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 1059–1068

    Chapter  Google Scholar 

  • Keers RY (1981) Laennec: his medical history. Thorax 36:91–94

    Article  PubMed  CAS  Google Scholar 

  • Lehmann J (1946) Para-aminosalicyclic acid in the treatment of tuberculosis. Lancet 1:15–16

    Article  PubMed  CAS  Google Scholar 

  • Lehmann J (1964) Twenty years afterward: historical notes on the discovery of the antituberculous effect of para-aminosalicyclic acid (PAS) and the first clinical trials. Am Rev Respir Dis 90:953–956

    PubMed  CAS  Google Scholar 

  • Lyons A, Petrucelli R (1978) Medicine, an illustrated history. Abrams, New York

    Google Scholar 

  • Maggi N, Pallanza R, Sensi P (1965) New derivatived of Rifamycin SV. Antimic. Agents Chemother 5:765

    CAS  Google Scholar 

  • Magner LN (ed) (1992) A history of medicine. Dekker, New York

    Google Scholar 

  • Magner LN (1992a) Islamic medicine. In: Magner LN (ed) A history of medicine. Dekker, New York, pp 133–152

    Google Scholar 

  • Magner LN (1992b) The scientific revolution and the circulation of the blood. In: Magner LN (ed) A history of medicine. Dekker, New York, pp 189–216

    Google Scholar 

  • McDermott W (1969) The story of INH. J Infect Dis 119: 678–683

    Article  PubMed  CAS  Google Scholar 

  • Meyer H, Malley J (1912) Hydrazine derivatives of pyridinecarboxyclic acids. Monatsh 33:393–414

    Article  CAS  Google Scholar 

  • Mitchison DA (1965) Chemotherapy of tuberculosis: a bacteriologis’s viewpoint. BMJ 1:1333–1340

    Article  PubMed  CAS  Google Scholar 

  • Murray JF (1989) The white plague: down and out, or up and Coming? Am Rev Respir Dis 140:1788–1795

    Article  PubMed  CAS  Google Scholar 

  • Myers JA (1977) Captain of all these men of death. Tuberculosis historical highlights. Green, St Louis

    Google Scholar 

  • Paulsen HJ (1987) Tuberculosis in the native American: indigenous or introduced? Rev Infect Dis 9:1180–1186

    Article  PubMed  CAS  Google Scholar 

  • Pfuetze KH, Pyle MM, Hinshaw HC et al (1955) The first clinical trial of streptomycin in human tuberculosis. Am Rev Tubercol 71:752–754

    CAS  Google Scholar 

  • Powell ML (1992) Health and disease in the late prehistoric southeast. In: Verano JW, Ubelaker DH (eds) Disease and demography in the Americas. Smithsonian Institution Press, Washington DC, pp 41–53

    Google Scholar 

  • Risse GB (1993) History of western medicine from Hippocrates to Germ theory. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 11–27

    Google Scholar 

  • Robitzek EH, Selikoff IJ (1952) Hydrazine derivatives of isonicotinic acid (Rimifon, Marsilid) in the treatment of active progressive caseous-penumonic tuberculosis. A preliminary report. Am Rev Tubercol 65:402–428

    CAS  Google Scholar 

  • Rogers FB (1969) The rise and decline of the altitude therapy of tuberculosis. Bull Hist Med 43:1–16

    PubMed  CAS  Google Scholar 

  • Rosenblatt MB (1973) Pulmonary tuberculosis: evolution of modern therapy. Bull NY Acad Med 49: 163–196

    CAS  Google Scholar 

  • Ryan F (1992) The Forgotten Plague: how the battle against tuberculosis was won and lost. Little Brown, Boston

    Google Scholar 

  • Sakula A (1981) RTH Laennec 1781-1826 his life and work: a bicentenary appreciation. Thorax 36:81–90

    Article  PubMed  CAS  Google Scholar 

  • Sensi PG, Greco AM, Ballotta R (1959/1960) Rifomycin I. isolation and properties of Rifomycin B and Rifomycin complex. Antibiot Annu 262

    Google Scholar 

  • Verano JW, Ubelaker DH (eds) (1992) Disease and demography in the Americas. Smithsonian Institution Press, Washington DC

    Google Scholar 

  • Weisse AB (1995) Tuberculosis: why “The white plague“? Perspect Biol Med 39:132–138

    PubMed  CAS  Google Scholar 

  • Wilson JL (1979) History of the American Thoracic Society. Am Rev Respir Dis 119:177–184

    PubMed  CAS  Google Scholar 

  • Wright KW (1988) A history of the Onondaga Sanatorium for the treatment of tuberculosis. NY State J Med 137–145

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Madkour, M.M., Al-Otaibi, K.E., Al Swailem, R. (2004). Historical Aspects of Tuberculosis. In: Madkour, M.M. (eds) Tuberculosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18937-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18937-1_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62365-3

  • Online ISBN: 978-3-642-18937-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics